The second goal was to assess the changes in GFAP isoform expression in AD-related reactive gliosis to test the hypothesis that a differential GFAP isoform expression may be involved in the morphological changes during gliosis, as previously described by our group for human AD [24], [25]. This evidence concerns the gene GFAP and Alzheimer disease.